CDSCO Expert Committee Accepts Phase IV Safety Data for Eisai’s Lenvatinib Capsules
The Subject Expert Committee (SEC) under India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has accepted the Phase […]
CDSCO
Drug Safety in India: CDSCO Crackdown, Kerala’s nPROUD Initiative, and the Fight Against Substandard Medicines
India’s pharmaceutical landscape witnessed a series of proactive measures in 2023-24, addressing critical issues like drug quality, combating spurious and […]
ENTOD Pharmaceuticals Introduces PresVu Eye Drops to Combat Presbyopia
In a groundbreaking development in the field of ophthalmology, ENTOD Pharmaceuticals has secured approval from the Central Drugs Standard Control […]
PIL in HC asks all remdesivir makers to be allowed to sell in the domestic market
A bench issued notice to the health ministry, CDSCO, DGFT, and various pharma companies, seeking their stand on the plea […]
MTaI welcomes CDSCO notice on ease of doing business for medical device sector
Medical Technology Association of India (MTaI) has welcomed two CDSCO notices which address operational and regulatory challenges faced by the […]
CDSCO confirms absence of formaldehyde in J&J baby shampoo
The Central Drugs Standard Control Organisation on Monday has strongly confirmed the validity of Johnson & Johnson’s baby shampoo stating […]
Industry demands revision of medical devices rules: AiMed
Disappointed at the recently published medical devices rules by the Ministry of Health and Family Welfare, the Association of Indian […]
